Basit öğe kaydını göster

dc.contributor.authorFisgin, Tunc
dc.contributor.authorAtmaca, Sinan
dc.contributor.authorDuru, Feride
dc.contributor.authorOzyurek, Emel
dc.contributor.authorCetin, Recep
dc.contributor.authorAlbayrak, Davut
dc.date.accessioned2020-06-21T15:06:27Z
dc.date.available2020-06-21T15:06:27Z
dc.date.issued2009
dc.identifier.issn0957-5235
dc.identifier.issn1473-5733
dc.identifier.urihttps://doi.org/10.1097/MBC.0b013e32831bec37
dc.identifier.urihttps://hdl.handle.net/20.500.12712/18611
dc.descriptionWOS: 000266148400014en_US
dc.descriptionPubMed: 19530341en_US
dc.description.abstractA 5-year-old boy was admitted to our center with a major complaint of bilateral hearing loss for 2 days. He was diagnosed with acute immune thrombocytopenic purpura 3 months before the admission and treated with high-dose methylprednisolone 2 months ago. Physical examination revealed wet purpura in the oral mucosa, serous nasal discharge, multiple petechiae and ecchymosis of the lower lip. Otomicroscopic ear examination revealed the presence of bilateral hemotympanum. The patient denied head trauma, ear pain, fever, hypertension and medications, including salicylates. The patient received high-dose intravenous methylprednisolone because of low platelet count and wet purpura for 7 days and oral prophylactic amoxicillin-clavulanate for 14 days. The onset of the response to corticosteroids was rapid, and significant hematologic improvement was observed within a few days. The 2-week follow-up examination revealed intact tympanic membranes with normal color and mobility, and the patient restored normal hearing. In this patient, hemotympanum developed rapidly, and no predisposing cause other than immune thrombocytopenic purpura was found. However, presence of a serous nasal discharge may be a sign of viral upper respiratory tract infection. Therefore, it can be speculated that sneezing or coughing might have caused bilateral hemotympanum by increasing the middle ear pressure abruptly. We would like to emphasize that bleeding may occur in unusual sites and, unlike in healthy people, may cause bizarre symptoms in patients with bleeding diathesis. Hemotympanum can be considered among the indications to start treatment in patients with acute immune thrombocytopenic purpura. Blood Coagul Fibrinolysis 20:303-305 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.en_US
dc.language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.isversionof10.1097/MBC.0b013e32831bec37en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjecthearing lossen_US
dc.subjecthemotympanumen_US
dc.subjectimmune thrombocytopenic purpuraen_US
dc.titleImmune thrombocytopenic purpura-related hemotympanum presenting with hearing lossen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume20en_US
dc.identifier.issue4en_US
dc.identifier.startpage303en_US
dc.identifier.endpage305en_US
dc.relation.journalBlood Coagulation & Fibrinolysisen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster